X4 Pharmaceuticals' earnings are $0.04, falling short of expectations, while profits exceed forecasts.

According to X4 Pharmaceuticals (NASDAQ: XFOR) report, the first-quarter earnings per share were -$0.200, which is $0.04 worse than analysts' expectations of -$0.160. The reported profit for this quarter was set at $1.43 million, while analyst expectations were at $990.71K.

X4 Pharmaceuticals stock closed at $0.29, indicating a -63.390% loss over the past three months and a -79.660% decline over the last 12 months. In the last 90 days, X4 Pharmaceuticals saw two positive earnings per share and one negative. Check here to see how X4 Pharmaceuticals stock price reacted to past earnings reports. According to InvestingPro, the financial health score for X4 Pharmaceuticals is rated as "Weak performance." Explore the latest earnings reports and all financial information for X4 Pharmaceuticals here and stay updated on all developments related to balance sheets by visiting the Investing.com Earnings Calendar.